Tag: clinical
NFL BIOSCIENCES: Agreement to grant its patent on NFL-101 in Europe and validation of the clinical development plan for NFL-101 by the EMA – 06/21/2023 at 18:15
NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of dependencies and addictions, announces that it has received approval from the…
Sensorion publishes promising preliminary data from the Phase 2a clinical study of Sens-401 – 06/19/2023 at 09:03
(AOF) – Sensorion, a pioneering clinical-stage biotechnology company dedicated to developing innovative therapies to restore, treat and prevent hearing loss, announces promising preliminary results from its Phase 1 proof-of-concept (POC)…
Biophytis presents the clinical results of Sarconeos (BIO101) in sarcopenia at the 16th international SCWD congress – 06/19/2023 at 07:00
Paris (France) and Cambridge (Massachusetts, United States), June 19, 2023 – 07:00 a.m. – Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a biotechnology company…
TME Pharma: the FDA approves a clinical trial in the USA – 06/15/2023 at 18:20
(CercleFinance.com) – TME Pharma announces today that the US Food and Drug Administration (FDA) has approved its request to launch a new clinical trial aimed at evaluating its main asset,…
TME Pharma: the FDA accepts a new clinical trial for Nox-A12 – 06/15/2023 at 18:24
(AOF) – TME Pharma announces today that after a complete review of the dossier submitted to it, the American Food and Drug Administration (FDA) has approved the request to launch…
TME Pharma: the FDA approves a clinical trial in the USA
(CercleFinance.com) – TME Pharma announces today that the US Food and Drug Administration (FDA) has approved its request to launch a new clinical trial aimed at evaluating its main asset,…
Pherecydes Pharma has submitted an application for authorization of a phase I clinical study in infective endocarditis caused by Staphylococcus aureus
By Hector Chaunu Published on 06/08/2023 at 07:35 Photo credit © ChaunuPictures (Boursier.com) — Pherecydes Pharmaa biotechnology company…
Pherecydes: application for clinical study authorization
(CercleFinance.com) – Pherecydes Pharma announced on Thursday that it had filed an application for authorization with the ANSM for a phase I clinical study in infective endocarditis caused by staphylococcus…
Pope Francis discharged from hospital after passing clinical tests
Italian agencies announced that the pope went to the hospital on Tuesday for less than an hour, the time to carry out check-ups. By NB with AFP The pope had…
Mauna Kea Technologies launches patient recruitment for its clinical study – 06/01/2023 at 18:13
(AOF) – Mauna Kea Technologies announces today the initiation of patient recruitment as part of a clinical study aimed at evaluating the ability of its Cellvizio platform to help physicians…
OSE Immuno: end of patient recruitment in the phase 2 clinical trial evaluating Tedopi in advanced pancreatic cancer
By Alexandra Saintpierre Published on 05/24/2023 at 6:19 p.m. (Boursier.com) — OSE Immunotherapeutics SA announces the end…
Valbiotis: After a clinical success for its dietary supplement against diabetes, Valbiotis jumps on the stock market
(BFM Bourse) – The company announced on Tuesday that a phase 2/3 clinical study evaluating this food supplement intended to prevent the onset of type 2 diabetes had reached its…